Stressgen Biotechnologies Corp (SSB.TO) Buy,…

Stressgen Biotechnologies Corp (SSB.TO)

0.00

-0.00 (0.00%)

0 watching

DON'T BUY

A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.

DON'T BUY

Trying to raise $50 million which is equivalent/more than their entire market cap.

PAST TOP PICK

(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.

TOP PICK

Holds this stock personally. Risky could double.

TRADE

A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.

DON'T BUY

Have restructured and will need more money.

BUY

Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.

DON'T BUY

On their watch list. Lost a lot of maney last year.

BUY ON WEAKNESS

A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.

BUY

They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.

BUY

Outlook is quite good and the price is at a good level.

BUY

At a good level. Has mad a good agreement with a large pharmaceutical.

WEAK BUY

In the final stage of their clinical trials. Will be a couple of years before you know if the product works.

WEAK BUY

Well along on the approval line. Product seems to be good. The sector is suffering. A higher risk.

WAIT

Fairly risky, but a good risk/reward ratio. In phase 3 trials. Could double if they get into a good partnership.

Showing 1 to 15 of 23 entries

Most Recent Experts

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Richard Orrell

RN Croft Financial Group

Stan Wong

Private Wealth Management, ScotiaMcleod

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stressgen Biotechnologies Corp (SSB.TO) Frequently Asked Questions

What is Stressgen Biotechnologies Corp stock symbol?

Stressgen Biotechnologies Corp is a OTC stock, trading under the symbol SSB.TO (previously SSB-T on Stockchase) on the undefined (undefined). It is usually referred to as or SSB.TO

Is Stressgen Biotechnologies Corp a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on SSB.TO (previously SSB-T on Stockchase) on Stockchase. Read the latest expert commentary for Stressgen Biotechnologies Corp.

Is Stressgen Biotechnologies Corp a good investment or a top pick?

Stressgen Biotechnologies Corp was recommended as a Top Pick by Peter Hodson on 2005-07-26. Read the latest stock experts ratings for Stressgen Biotechnologies Corp.

Why is Stressgen Biotechnologies Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Stressgen Biotechnologies Corp.

Is Stressgen Biotechnologies Corp worth watching?

Stressgen Biotechnologies Corp is covered by Stockchase experts and is worth watching.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Stressgen Biotechnologies Corp (SSB.TO)